CTOs on the Move


 
Humans across the globe and of all walks of life want to live at their personal best, and are seeking more natural alternatives to feeling their best and getting the most out of life. Today, they are discovering the answer through natural cannabinoid products. At the same time, science and technology are unlocking the future potential of cannabinoids. We believe that cannabinoids, when used responsibly, have the power to enhance the full spectrum of well-being and to help us live healthier and happier lives. Parallel is improving the well-being of our consumers today through our proprietary, innovative ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.liveparallel.com
  • 55 Ivan Allen Junior Boulevard North West Suite 900
    Atlanta, GA USA 30308
  • Phone: N/A

Executives

Name Title Contact Details
Ken Thompson
Director Infrastructure, Service and Information Security Profile

Similar Companies

Menlo Therapeutics

We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.

Occupational Environmental Health Solutions

Occupational Environmental Health Solutions is a Chatham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chicago Hospital Risk Pooling Program

Chicago Hospital Risk Pooling Program is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RECKITT BENCKISER NORTH AMERICA

RECKITT BENCKISER NORTH AMERICA is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Life Support Technologies Group

Life Support Technologies Group is a Valhalla, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.